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Abstract
Background: With regards to the high potential of medicinal plants in the production of biopharmaceuticals, one can rely on the
promising prospect of insulin production via plant resources.
Objectives: This study was conducted with the aim of using plant extract for insulin-producing cells.
Methods: This was a quasi-experimental study using critical case sampling. Six samples were gathered from the umbilical cord
(Wharton’s jelly) in a governmental university affiliated hospital, Sari, Iran in 2017 after successful isolation of mesenchymal stem
cells. Initially, Nigella sativa seeds extraction was performed to prepare the extract for cellular differentiation. Next, dithizone (DTZ)
staining was used to evaluate insulin production, and insulin level was examined by the enzyme-linked immunosorbent assay
(ELISA). Data were analyzed was analyzed with the SPSS version 16 software using independent sample t-test.
Results: The mean of the amount of insulin secretion was 92.33±5.13 ng/ml for the intervention and 0.33±0.15 ng/ml for the control
group. The results showed that there was a significant difference in the average insulin in the culture obtained from Nigella sativa
seeds between control and intervention groups (P = 0.001). In addition, via the ELISA kit and specific dithizone staining, insulin-
producing cells were proven.
Conclusions: In this regard, it could be concluded that the extract of Nigella sativa seeds was capable of including differentiation
of mesenchymal stem cells derived from Wharton’s jelly to Insulin-Producing Cells.
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1. Background
Diabetes mellitus is the most common metabolic dis-
order around the world (1). According to the international
diabetes federation (IDF), it is estimated that 382 million
people worldwide have diabetes (2-4). Furthermore, um-
bilical cord and Wharton‘s jelly (the vessels out of the um-
bilical cord) are better sources for Mesenchymal stem cells
(MSCs), since they are globally accessible tissues and their
gathering does not lead to any ethical harm, as they are
ordinarily disposed as human waste (5-7). mesenchymal
stem cells are seen as the most important candidate for cel-
lular therapy. This fact is well-documented by the research
literature carried out in vitro, under preclinical and clini-
cal conditions (8).
Flavonoids have been studied extensively due to their
antioxidant properties. In addition, these compounds
have been used to induce cellular differentiation (9-12). In
a study conducted on Myrtus leaf extract (2016), it was clar-
ified that the extract of this plant significantly reduced glu-
cose levels in diabetic rats (13).
Nigella sativa (N. sativa) belongs to the botanical family
of Ranunculaceae and commonly grows in Eastern Europe,
Middle East, and Western Asia (14, 15). The most important
bioactive compounds of N. sativa include alkaloids, thymo-
quinone, riboflavin, pyridoxine, niacin, folic acid, proteins,
and minerals (14, 15).
The differentiation of MSCs to Insulin-Producing Cells
(IPCs) is one of the new methods for the treatment of dia-
betes, particularly diabetes type I (16).
In regards to the ever-increasing demand for the manu-
facture of insulin, it has led to the development of inexpen-
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sive, cost-effective, high-capacity, and high-quality prod-
ucts associated with the manufacturing units. Since there
is a high potential of plants to produce biomaterials by us-
ing molecular farming, the production and supply of in-
sulin from plants could also be a promising prospect for
the human society. Up till now, many researches have been
conducted to generate mesenchymal stem cells and iden-
tify their differentiation to pancreatic beta cells by using
different molecules; however, previous studies have failed
to produce complete pancreatic beta cells.
The present study aimed at isolating mesenchymal
stem cells from Wharton jelly and differentiating them us-
ing the extract of Nigella sativa seeds in cellular culture to
insulin-producing cells (IPCs). Thus, a new
2. Methods
2.1. Collection of Human Umbilical Cord
The present quasi-experimental study used the critical
case sampling method and human umbilical cord samples
were collected in thoroughly sterilized conditions from six
mothers after delivery/childbirth at the obstetrical depart-
ment of Imam educational and therapeutic hospital in Sari
city, North of Iran in 2017. Since the umbilical cord is a
waste, an informed consent was taken from all six mothers
with caesarian delivery.
2.2. Statistical Analysis
The mean and SD were calculated for amount of insulin
secretion in the intervention and control group. The nor-
mality of groups was examined. The t-test was applied for
comparison of the amount of insulin secretion between
the intervention and control groups. The homogeneity of
variance between the two groups was examined with Lev-
ene’s test for equality of variance. To estimate the param-
eter and significance levels more accurately, the bootstrap
technique and a sample size of 1500 was used. All data were
entered and analyzed in the SPSS statistics for Windows,
version 16.0, (SPSS Inc. Chicago, ILL, USA) software. The sig-
nificance level was predetermined at P = 0.001.
2.3. Wharton’s Jelly Culture
First, all clots and arteries of umbilical cord were iso-
lated under laminar hood via a 10-mm plate. Then, the
gelatinous substance within the umbilical cord, known
as Wharton jelly, was cut to small pieces mechanically
and rinsed several times with phosphorous buffered saline
(PBS) at 1250 RPM for 5 minutes. For lysing the remain-
ing RBC, 2 mL of hypertonic chloride and ammonium (USA,
Pharmin Gen) was added to each sample and was rinsed
after 10 minutes. The cell pellet included cell separations
from the placenta tissue transferred to a T75 Flask and
was cultured in high glucose-Dulbecco’s modified eagle
medium-F12 (HG- DMEM-F12) (USA, Gibco) supplemented
with 15 % fetal bovine serum (FBS) and 50µg/mL penicillin-
streptomycin. The plate was incubated in 5% CO2 at 37°C.
2.4. Mesenchymal Stem Cells Isolated from Other Umbilical
Cord Cells
The medium was changed after 24 hours and the sus-
pended particles (non-mesenchymal cells) migrated from
the medium and the mesenchymal cells adhered to the
flask and turned to spindle-like shapes. When the con-
fluency of the cells reached 80% to 90%, the mesenchy-
mal cells were harvested using 0.25% trypsin, including 1
ml/M EDTA (Sigma, USA). The suspension was centrifuged
at 1250 RPM for 5 minutes. The cell pellet was rinsed twice
and centrifuged. Finally, it was filtered using a grade 70
micron filter. In order to approve MSCs’ identity, posi-
tive markers of stem cell surface, i.e. CD105, CD90, CD44,
and negative markers, i.e. CD34 and HLA-DR, were evalu-
ated by flow cytometry. Conjugating related antibodies,
Fluor chromes FITC, PE, and PerCP were also applied to con-
trol Isotypes PerCP, PE, and IgG1-FITC. Additionally, WJ-MSCs
were cultured in appropriate medium to evaluate the dif-
ferentiation capacity of MSCs towards the adipocytes, os-
teocytes, and chondrocytes. Subject to the confirmation of
adipocytes differentiation, the cells were stained with oil-
red-O (Sigma, USA). In contrast, for the differentiation of os-
teocytes, the differentiated cells were stained with alizarin
red and thereof calcium deposition was confirmed. For the
differentiation of chondrocyte, cells were stained with Al-
cian blue.
2.5. The Preparation Method of Plant Extraction
The seeds of Nigella sativa, which were purchased from
a local market, were identified at the herbarium of phar-
macy school, Mazandaran University of Medical Sciences,
Iran. The hydro-alcoholic extract was prepared as de-
scribed previously (17).
Powdered seeds (100 g) of N. sativa, including 355
meshes were milled and sieved, then incubated in 300 mL
of ethyl alcohol 70% in a Soxhlet extractor. The extraction
with ethanol was continued on the residue and then con-
centrated in a rotary evaporator and kept at -20°C before
use. In order to obtain the desired concentrations, the ex-
tract rates of 0.5, 1, and 2 g were dissolved in 1000-mL of
drinking water, respectively (18). Fifteen grams of the prod-
uct was added to 250 mL of solvent (ethanol-water 1 to 7)
from this plant and placed in water at 100°C for 40 min-
utes. Then the extract was dilated with several millipore
of filter paper. The extract was acidified by acidic chloride
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and stirred by the range of 100 mL with ethyl acetate three
times in each phase. The ethyl acetate extract was dried
on a rotary evaporator (EYELA Japanese N1000SW220V-IP)
at 40°C. Finally, the flavonoid extract of the seeds of Nigella
sativa was exposed to -20°C storage (19, 20).
2.6. The Differentiation of Mesenchymal Stem Cells to Insulin
Producing Cells (IPCs) by Extract of Nigella Sativa Seeds
The resulting cell source was placed in an incubator
for 6 - 10 minutes and then differentiated by using Nigella
sativa seeds in the cell culture after approximately day 28 of
the production of the insulin producing cells (IPCs). In or-
der to optimize the extract of the plant determined in dif-
ferent dilutions, this study examined the culture in order
to obtain the optimum dilution. In the present study, 300
µg/mL of plant extract was used in culture at a ratio of 1 to
10 (plant extract to culture).
The culture of differentiated cells was tested by using a
standard enzyme linked immunosorbent assay (ELISA) Kit
(Demeditec Diagnostics GmbH, Germany-DE2935). Insulin
infusion was investigated in the extract of Nigella sativa
seeds.
2.7. Differentiation of Mesenchymal Stem Cells to Insulin-
Producing Cells
Following isolation and confirmation of MSCs, the
optimization of Nigella sativa at various dilutions was
checked in the culture and the optimum dilution was ob-
tained. Then the induction of treatment was conducted
during 3 to 5 days.
2.8. Dithizone Staining
Fifty milligrams of dithizone (Merck) was dissolved in
5 mL of dimethyl sulphoxide (Sigma, USA) and the final so-
lution was kept as a stock at -20°C. Then, 10 µM of dithi-
zone solutions were added to the cells and they were in-
cubated for 15 minutes. Insulin-producing cells are cells,
which turn red as a result of staining.
3. Results
The mean of the amount of insulin secretion was 92.33
± 5.13 in the intervention and 0.33± 0.15 ng/ml in the con-
trol group. Shapiro-wilk test of normality (Table 1) showed
that for intervention and control groups, the dependent
variable of the amount of insulin secretion was normally
distributed (P = 0.001). The result of Levene’s test showed
that the variance between the 2 groups weren’t equal and
independent sample t-test was performed with equal vari-
ance not assumed (Table 2). The result of the t-test showed
that there was a significant difference between the mean
Table 1. Test of Normality for Amount of Insulin Secretion in Intervention and Con-
trol Groups
Variables Shapiro-Wilk Test of Normality
Statistics df Sig.
Intervention 0.95 3 0.57
Control 0.96 3 0.64
Abbreviation: df, Degree of Freedom.
Table 2. Independent Sample T-Test for Evaluation of Mean Difference of Amount of






Std. error difference 2.96
95% confidence interval of difference
Lower 79.26
Upper 104.73
of the amount of insulin secretion between the 2 groups (P
= 0.001).
The result of the bootstrap technique used in this study
showed that estimation of parameter was exact and had
precision (Table 3).





95% confidence interval of difference
Lower 79.26
Upper 104.73
In the current study, Wharton Jelly’s mesenchymal
stem cells (WJ-MSCs) were differentiated to insulin-
producing cells (IPCs). For this purpose, after isolation
and differentiation of WJ-MSCs to IPCs, a morphological
and molecular analysis was performed.
3.1. Morphological and Phenotypical Characterization of Whar-
ton Jelly’s Mesenchymal Stem Cells
At the end of the expansion phase, the cultured WJ-
MSCs became homogenous with spindle-shape and akin to
fibroblast-like to be arranged in monolayers (Figure 1).
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Figure 1. The Wharton’s Jelly Mesenchymal Cells Were Grown from the Edge of Tis-
sue Explants and Homogenous Population of Fibroblast-Like Mesenchymal Stem
Cells at Passage 2 (× 100)
3.2. Immunophenotyping of Wharton Jelly’s Mesenchymal Stem
Cells
The immunophenotypes of WJ-MSCs were analyzed by
flow cytometry. The results showed that WJ-MSCs were pos-
itive for CD90 (99.30%), CD105 (96.37%) and CD44 (83.11%),
and were negative for hematopoietic marker CD34 (0.72%)
and HLA-DR (0.85%) (Figure 2).
3.3. Dithizone (DTZ) Staining
In order to evaluate insulin production in clusters at
day 21 of differentiation, the researchers used dithizone
(DTZ) staining. The stock solution was prepared as pre-
viously described (16), thereby 50 mg of DTZ was com-
pletely dissolved (Sigma , USA) in 5 mL of dimethyl sulfox-
ide (DMSO, Sigma, USA). The solution was stored at -20°C
in a dark bottle. In the staining phase, the working solu-
tion was prepared by diluting the stock solution (pH 7.8)
at a ratio of 1:100 in culture medium. Three milliliters of
the working DTZ solution was added to each one and the
plates were incubated for 30 minutes at 37°C. The plates
were then rinsed 3 times with PBS and crimson-red differ-
entiated clusters; therefore, they were examined with an
inverted phase contrast microscope (Figure 3).
3.4. Enzyme Linked Immunosorbent Assay Test
In order to determine the amount of insulin secreted
by the differentiated cells after day 28, the cell culture
medium was examined using the ELISA kit technique. The
results showed that the differentiated cells, in comparison
with the undifferentiated cells, secreted insulin. The re-
searchers could successfully differentiate MSCs to insulin-
producing cells. However, there was a significant differ-
ence between the level of insulin in the supernatant of the
culture obtained from the extract of Nigella sativa seeds in
comparison with the negative control group (P = 0.001).
The insulin secretion level of 92.3 u/mL was obtained by the
extract of Nigella sativa seeds.
4. Discussion
Medicinal herbs are effectual in the treatment of many
diseases, including diabetes (10, 21).
In the present study, after successful isolation of mes-
enchymal stem cells (MSCs) and confirmation by fixing fi-
broblastic cells to the flask floor and checking the CD, the
positive and negative markers were determined by flow cy-
tometry in the next step in order to differentiate to pancre-
atic beta cells by using the extract of Nigella sativa seeds. By
optimizing its concentration at different dilutions in cul-
ture, the researchers were able to obtain the proper pro-
duction of insulin cells (IPCs). The significant signs of the
pancreatic beta cells were observed in the insulin secre-
tion. In the present study, the amount of insulin secretion
by using the extract of Nigella sativa seeds was determined
to differentiate the mesenchymal stem cells (MSCs) and in-
sulin producing cells (IPCs) using the ELISA Kit; the level of
insulin secretion was 92.3 u/mL, while in the negative con-
trol group, there was a very low level of insulin. Differen-
tiation to pancreatic β-cells was achieved with the extract
of Nigella sativa seeds and its concentration was optimized
by a variety of dilutions in the culture. Then, this study suc-
ceeded to produce IPCs. It was examined by ELISA and DTZ
exclusive dyeing.
In summary, the extract of Nigella sativa seeds could
induce the differentiation of mesenchymal stem cells de-
rived from Wharton jelly to IPCs with an appropriate in-
sulin release.
It is suggested that in order to examine the perfor-
mance of the IPCs obtained in this research by the extract
of Nigella sativa seeds in the therapeutic procedures, cell
therapy and transplantation of these cells in animals with
diabetes and the evaluation of glucose level improvement
and its effectiveness should be investigated in future work
compared with common insulin. In respect to its role, it
is an essential element in the effectiveness of the internal
environment, which could be distinguished from induced
treatments outside of the body. Due to the advantage of
the role of the bodily internal environment, which can be
applied in cellular differentiation from bodily external en-
vironments, it is an important point. Also in the future,
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Figure 2. Flow Cytometry Analysis of Mesenchymal Stem Cells Derived from Wharton’s Jelly
Figure 3. Dithizone (DTZ) Staining: Observed with Inverted Microscope and Magnified× 100
A, Untreated cells (negative control); B, Intervention cells with insulin granules come in red brick.
the focus of the research should be on anti-diabetic mech-
anisms of Nigella sativa seeds.
4.1. Conclusion
According to the present study, it could be concluded
that Nigella sativa seeds have an effect on the process of dif-
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ferentiation of the mesenchymal stem cells derived from
Wharton’s jelly (WJ-MSCs) toward insulin producing cells
(IPCs).
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